It was found that SIRT3 activates SOD2 and catalase to block cardiac hypertrophy in primary cardiomyocytes cultures, thereby decreasing ROS levels (Sundaresan et al., 2009). This evidence concerns the gene SOD2 and cardiac hypertrophy.